ID20742A - Penggunaan donor-donor oksida nitrat dan/atau untuk mengatur pelebaran dan perluasan leher rahim - Google Patents

Penggunaan donor-donor oksida nitrat dan/atau untuk mengatur pelebaran dan perluasan leher rahim

Info

Publication number
ID20742A
ID20742A IDP960631A ID960631A ID20742A ID 20742 A ID20742 A ID 20742A ID P960631 A IDP960631 A ID P960631A ID 960631 A ID960631 A ID 960631A ID 20742 A ID20742 A ID 20742A
Authority
ID
Indonesia
Prior art keywords
expansion
nitric oxide
regulation
donors
oxidate
Prior art date
Application number
IDP960631A
Other languages
English (en)
Indonesian (id)
Inventor
Kristof Dr Chwalisz
Robert E Garfield
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ID20742A publication Critical patent/ID20742A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
IDP960631A 1995-03-14 1996-03-14 Penggunaan donor-donor oksida nitrat dan/atau untuk mengatur pelebaran dan perluasan leher rahim ID20742A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95250059 1995-03-14

Publications (1)

Publication Number Publication Date
ID20742A true ID20742A (id) 1999-02-25

Family

ID=8221039

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP960631A ID20742A (id) 1995-03-14 1996-03-14 Penggunaan donor-donor oksida nitrat dan/atau untuk mengatur pelebaran dan perluasan leher rahim

Country Status (26)

Country Link
US (1) US6333350B1 (pl)
EP (1) EP0814785B1 (pl)
JP (1) JP4579349B2 (pl)
KR (2) KR100434239B1 (pl)
CN (1) CN1151781C (pl)
AT (1) ATE377417T1 (pl)
AU (1) AU713172B2 (pl)
CA (1) CA2214779A1 (pl)
CZ (1) CZ292395B6 (pl)
DE (1) DE69637313T2 (pl)
ES (1) ES2297838T3 (pl)
HU (1) HUP9800826A3 (pl)
ID (1) ID20742A (pl)
IL (1) IL117496A (pl)
IS (1) IS4555A (pl)
MX (1) MX9707007A (pl)
MY (1) MY116500A (pl)
NO (1) NO318598B1 (pl)
NZ (1) NZ305169A (pl)
PL (1) PL183461B1 (pl)
RU (1) RU2199346C2 (pl)
SK (1) SK124197A3 (pl)
TW (1) TW421594B (pl)
UA (1) UA57703C2 (pl)
WO (1) WO1996028145A1 (pl)
ZA (1) ZA962089B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2199346C2 (ru) 1995-03-14 2003-02-27 Шеринг Аг Применение доноров оксида азота или ингибиторов оксида азота для регулирования раскрытия и растяжения шейки матки
WO1997031631A1 (en) * 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
ITMI20002117A1 (it) * 2000-09-29 2002-03-29 Ibsa Inst Biochimique Sa Uso di sodio nitroprussiato in ostetricia e ginecologia
WO2005023189A2 (en) * 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN102283827A (zh) * 2008-10-16 2011-12-21 四川维信医药科技有限责任公司 单硝酸异山梨酯的新用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508045A (en) 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
EP0730448B1 (en) * 1993-11-16 2002-02-06 Schering Aktiengesellschaft Use of nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor for the manufacture of medicaments for the treatment of uterine contractility disorders
US5550369A (en) 1994-02-28 1996-08-27 Electro-Pro, Inc. Triangulation position detection method and apparatus
RU2199346C2 (ru) 1995-03-14 2003-02-27 Шеринг Аг Применение доноров оксида азота или ингибиторов оксида азота для регулирования раскрытия и растяжения шейки матки

Also Published As

Publication number Publication date
IL117496A (en) 2002-12-01
DE69637313T2 (de) 2008-09-04
CA2214779A1 (en) 1996-09-19
ATE377417T1 (de) 2007-11-15
KR100434239B1 (ko) 2004-06-09
EP0814785A1 (en) 1998-01-07
KR100434238B1 (ko) 2004-07-16
NO974204D0 (no) 1997-09-12
NO974204L (no) 1997-11-13
NO318598B1 (no) 2005-04-18
TW421594B (en) 2001-02-11
NZ305169A (en) 1999-10-28
JP4579349B2 (ja) 2010-11-10
HUP9800826A3 (en) 1998-08-28
IL117496A0 (en) 1997-03-18
ES2297838T3 (es) 2008-05-01
AU713172B2 (en) 1999-11-25
MX9707007A (es) 1998-06-30
CN1182366A (zh) 1998-05-20
RU2199346C2 (ru) 2003-02-27
UA57703C2 (uk) 2003-07-15
KR20040004515A (ko) 2004-01-13
JPH11502200A (ja) 1999-02-23
KR19980703060A (ko) 1998-09-05
EP0814785B1 (en) 2007-11-07
ZA962089B (en) 1997-08-27
SK124197A3 (en) 1998-06-03
IS4555A (is) 1997-09-05
AU5311796A (en) 1996-10-02
CN1151781C (zh) 2004-06-02
PL322252A1 (en) 1998-01-19
MY116500A (en) 2004-02-28
CZ292395B6 (cs) 2003-09-17
HUP9800826A1 (hu) 1998-07-28
WO1996028145A1 (en) 1996-09-19
PL183461B1 (pl) 2002-06-28
DE69637313D1 (de) 2007-12-20
CZ285197A3 (cs) 1998-03-18
US6333350B1 (en) 2001-12-25

Similar Documents

Publication Publication Date Title
DE69534755D1 (de) Vorrichtung für die Verabreichung von Phosphodiesterase-Hemmern
MX9700237A (es) Combinaciones inhibidoras de proteasa retroviral.
NO164092C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrebaserte kollagenaseinhibitorer.
ID20742A (id) Penggunaan donor-donor oksida nitrat dan/atau untuk mengatur pelebaran dan perluasan leher rahim
DK0690851T3 (da) Guanidin-derivater, som er anvendelige til behandling
WO1994012165A3 (en) Enzyme inhibitors
NO952469D0 (no) Terapautisk kombinasjon som inneholder interferon
NO932388D0 (no) Fremgangsmaate til fraktur-syrebehandling av undervannsformasjoner
FI953954A (fi) HIV:n käänteistranskriptaasin inhibiittoreita
AU5635396A (en) Alpha-substituted pyrimidine-thioalkyl and alkylether compounds
NO307687B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av neuro-AIDS
NO943597L (no) Klebende/mekanisk festesystem for kasserbar absorberend gjenstand
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
NO178546C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive ACE-hemmere med nootrop virkning
HUP9901353A2 (hu) ACE-inhibitorok alkalmazása diszpepsziás tünetek kezelésére alkalmas gyógyszerkészítmény előállítására
PT730448E (pt) Utilizacao de um substrato de sintetase e/ou dador de oxido nitrico ou um inibidor de oxido nitrico para o fabrico de medicamentos para o tratamento de desordens da contractilidade uterina
FI925144A (fi) Anvaendning av inhibitorer foer faergutvecklingen i kromogena bestaemningar
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
HUP0004298A2 (hu) Endotelin antagonista imidazolszármazékok és renin-angiotenzin-rendszer inhibitorok mint kombinációs készítmények és eljárás ezek előállítására
AU6144686A (en) Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
NO951608D0 (no) Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon
FI950696A (fi) Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä
SE8403449L (sv) Narkos- och/eller respiratoranleggning med mangsidig utnyttjande av behandlingsgasen
ATE184487T1 (de) Transdermales therapeutisches system für silatranverbindungen